
Westlake Chemical Partners LP (NYSE: WLKP) reported second-quarter EPS of $0.41, missing analyst estimates of $0.45, and revenue of $297.12 million, falling short of the $301 million consensus. The company's stock closed at $21.80, reflecting declines of 6.03% over the last three months and 5.22% over the past year, despite InvestingPro rating its financial health as 'good performance'.
Westlake Chemical Partners LP (WLKP) reported second-quarter results that fell short of market expectations on both the top and bottom lines. The company posted an EPS of $0.41, missing the consensus estimate of $0.45, while revenue of $297.12 million also came in below the anticipated $301 million. This operational underperformance aligns with recent negative stock price momentum, as the stock has declined 6.03% over the past three months and 5.22% over the last twelve months. Further underscoring a weakening outlook, the company has seen one negative EPS revision and no positive revisions over the last 90 days, suggesting analyst sentiment was already deteriorating prior to the release. Despite these headwinds from the earnings miss and negative price action, an InvestingPro assessment rates the company's financial health as "good performance," indicating potential underlying balance sheet strength that contrasts with the recent operational results.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment